Medical Crossfire®:The Contemporary Management of Hypoparathyroidism


Release Date: November 30, 2017
Expiration Date: November 30, 2018
Media: Internet - based

Activity Overview

During this Medical Crossfire, expert faculty in the field of endocrinology will engage in a roundtable discussion that includes an endocrinologist, an endocrine surgeon, a physician assistant, and a primary care professional to discuss the most recent developments in the diagnosis and management of hypoparathyroidism. Unlike primary hyperparathyroidism, which is relatively common, hypoparathyroidism has not received the same level of attention and discussion until recently, as new guidelines have been developed to help clinicians diagnose, evaluate, and manage this disorder. Concomitantly, the recent approval of recombinant human PTH replacement therapy is expected to result in dramatic changes to the treatment landscape for this condition. This panel discussion includes experience-based strategies for improving diagnosis, highlights of the new treatment guidelines, and both conventional and novel treatment pathways. The program concludes with case studies to demonstrate the application of the new evidence-based guidelines.

Acknowledgement of Commercial Support

This educational activity is supported by an independent medical educational grant from Shire. This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC.

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

Endocrinologists, surgeons, internists, and other healthcare professionals with interest in hypoparathyroidism

Learning Objectives

At the completion of this activity, the participant will be able to:

  • ARTICULATE the burden, clinical presentation, and diagnostic features of hypoparathyroidism
  • DETERMINE the benefits and challenges of conventional treatment with calcium and vitamin D
  • EXPLAIN the efficacy, safety, and role of parathyroid hormone replacement therapy in the management of hypoparathyroidism
  • INTEGRATE new guidelines on the diagnosis and management of hypoparathyroidism



Stephen Brunton, MD
Executive Director
Primary Care Metabolic Group
Los Angeles, California
Peter Angelos, MD, PhD, FACS
Linda Kohler Anderson Professor of Surgery and Surgery Ethics
Chief, Endocrine Surgery
Associate Director, MacLean Center for Clinical Medical Ethics
The University of Chicago
Chicago, Illinois
Ji (CJ) Chun, PA-C, MPAS
Physician Assistant, OptumCare Medical Group: Endocrinology
Orange County, California
President, American Society of Endocrine Physician Assistants
Adjunct Faculty, A.T. Still University/Arizona School of Health & Sciences
Mesa, Arizona
Professor of Clinical M

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.


Become a Member

Forgot Password?
Calendar of Events
Filter By